{"public_id":"cl_105f205412ac4d1bd2169822ec400462","status":"active","superseded_by_public_id":null,"corpus_id":1480278,"text":"Adding a second daily aspirin dose significantly reduced platelet reactivity between 81 mg once daily and 81 mg twice daily, and between 81 mg once daily and 162 mg twice daily, as measured by collagen-induced aggregation and the VerifyNow-Aspirin assay (P<0.05 for both comparisons and assays).","confidence":0.9,"paper":{"corpus_id":1480278,"title":"Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease","url":"https://sah.borca.ai/papers/1480278"},"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.9,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_53c2ba57653c5103d3c568a42adef476","name":"VerifyNow-Aspirin assay","description":"A point-of-care platelet function assay used in this study to assess aspirin's antiplatelet effect.","types":["measurement technique"],"url":"https://sah.borca.ai/concepts/co_53c2ba57653c5103d3c568a42adef476"},{"public_id":"co_5c47ebcaf5f509fef5a759e6c6174923","name":"collagen-induced aggregation","description":"A light-transmittance aggregometry assay measuring platelet aggregation in response to collagen stimulation.","types":["measurement technique"],"url":"https://sah.borca.ai/concepts/co_5c47ebcaf5f509fef5a759e6c6174923"},{"public_id":"co_9c861446b139faa24eb20dbd0300bfe9","name":"twice-daily aspirin administration","description":"Splitting the aspirin dose into two doses per day (bid) in the study's dosing scheme.","types":["method"],"url":"https://sah.borca.ai/concepts/co_9c861446b139faa24eb20dbd0300bfe9"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_105f205412ac4d1bd2169822ec400462"}